ACROBiosystems Cell & Gene Tech Expo August 2025: Cell Therapy

Traditional cell culture media often fail to meet the unique metabolic and cytokine requirements of specific immune cell subpopulations, hindering progress in cell therapy development. Gamma-delta (γδ) T cells, for example, hold immense potential for allogeneic therapies due to their MHC-independent antigen recognition and lower risk of graft-versus-host disease, but they can be difficult to expand effectively.

A specialized, chemically defined medium designed specifically for their needs can overcome these hurdles. Data demonstrates this targeted approach can achieve remarkable growth, yielding a >20,000-fold expansion of γδ T cells from PBMCs while maintaining high purity. This level of robust and scalable expansion is essential for translating promising research into viable clinical manufacturing.

Watch the full presentation to explore the complete data set and learn how a specialized culture strategy can advance your cell therapy pipeline.